Sagimet Biosciences Inc. employees and revenue per employee

SGMT · Biotechnology · $333M market cap

Sagimet Biosciences Inc. had 10 employees at the end of fiscal Dec 2023. Revenue for the year was $2.0M, or $200K per employee.

The latest annual report we hold is more than two years old, so these numbers may be out of date.

Employees

10

Revenue

$2.0M

Revenue / employee

$200K

Peer median $455K

Rank in industry

82 of 111

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

Only one fiscal year on file so far, so there is no trend to draw yet.

Employees, last six fiscal years
10'23
Revenue per employee, last six fiscal years
$200K'23

Sagimet Biosciences Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

CompanyEmployeesRevenueRevenue / employeeShape
SGMT
Sagimet Biosciences Inc.
10$2.0M$200K—
CGON
CG Oncology Inc.
142$4.0M$28KEfficient growth
STTK
Shattuck Labs, Inc.
40$1.0M$25KContracting
DNTH
Dianthus Therapeutics, Inc.
92$2.0M$22KHiring into decline
ABSI
Absci Corporation
140$2.8M$20KContracting
INBX
Inhibrx Biosciences Inc.
109$1.3M$12KLeaner
NGNE
Neurogene Inc.
107$925,000$9K—
CLDX
Celldex Therapeutics, Inc.
198$1.5M$8KHiring into decline
AKTS
Aktis Oncology, Inc.
200,000$6.5M$32—
Every Healthcare company

Questions about Sagimet Biosciences Inc.

How many employees does Sagimet Biosciences Inc. have?
Sagimet Biosciences Inc. reported 10 employees for the fiscal year ending Dec 2023, in the annual report it filed on March 25, 2024.
What is Sagimet Biosciences Inc.'s revenue per employee?
Sagimet Biosciences Inc. brought in $2.0M of revenue in fiscal Dec 2023, which is $200K per employee. That ranks 82 of 111 companies we track in Biotechnology, where the median is $455K.
Where do these numbers come from?
Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

This page is the filings. The research is a membership.

On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

Compare SGMT with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Source: employee counts and revenue as stated in Sagimet Biosciences Inc.'s annual reports (Form 10-K), latest filed March 25, 2024. This is data, not a recommendation to buy or sell SGMT.